Christoph Oing (C Oing)

Scopus Author ID Loop profile Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

World journal of urology

Andrology

Molecular oncology

Journal of experimental & clinical cancer research : CR

The Christie NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Christie NHS Foundation Trust Oct 01 2018

United Kingdom

Honorary Fellow :: Medical Oncology

Manchester Cancer Research Centre Oct 01 2018

United Kingdom

Research Fellow :: Translational Oncogenomics Group

University Medical Center Hamburg-Eppendorf Oct 15 2010

Germany

Resident :: Oncology, Hematology & Stem Cell Transplantation with Section of Pneumology

Publications

Christoph Oing, Marcus Hentrich
[Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours]. Aktuelle Urologie (2024)
Mohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing, Alicia Eckhardt, Susanne Burdak-Rothkamm, Malik Alawi, Christian Müller, Ulrich Schüller, Tobias Maurer, Gunhild von Amsberg, Cordula Petersen, Kai Rothkamm, Wael Yassin Mansour
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease. Molecular oncology (2023)
Mohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing, Alicia Eckhardt, Susanne Burdak-Rothkamm, Malik Alawi, Christian Müller, Ulrich Schüller, Tobias Maurer, Gunhild von Amsberg, Cordula Petersen, Kai Rothkamm, Wael Yassin Mansour
Preclinical patient-derived modelling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease. Molecular oncology (2023)
Christoph Seidel, Marcus Hentrich, Stefanie Zschäbitz, Pia Paffenholz, Axel Heidenreich, Tim Nestler, Ben Tran, Stefanie Fischer, Gedske Daugaard, Sebastian Ochsenreither, Margarida Brito, Friedemann Zengerling, Constantin Schwab, Carsten Bokemeyer, Christoph Oing
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG). World journal of urology 40 (2) (2022)
Dennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, Lambert C J Dorssers, Ad J M Gillis, Silvia Schmidtova, Katarina Kalavska, Harmen J G van de Werken, Christoph Oing, Friedemann Honecker, Michal Mego, Leendert H J Looijenga
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
David Pfister, Karin Oechsle, Stefanie Schmidt, Jonas Busch, Carsten Bokemeyer, Axel Heidenreich, Julia Heinzelbecker, Christian Ruf, Christian Winter, Friedemann Zengerling, Sabine Kliesch, Peter Albers, Christoph Oing
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment : A comprehensive review compiled by the German Testicular Cancer Study Group. World journal of urology 40 (12) (2022)
Michal Chovanec, Jakob Lauritsen, Mikkel Bandak, Christoph Oing, Gry Gundgaard Kier, Michael Kreiberg, Josephine Rosenvilde, Thomas Wagner, Carsten Bokemeyer, Gedske Daugaard
Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature reviews. Urology 18 (4) (2021)
Julia Heinzelbecker, Stefanie Schmidt, Julia Lackner, Jonas Busch, Carsten Bokemeyer, Johannes Classen, Annette Dieing, Oliver Hakenberg, Susanne Krege, Alexandros Papachristofilou, David Pfister, Christian Ruf, Hans Schmelz, Heinz Schmidberger, Rainer Souchon, Christian Winter, Friedemann Zengerling, Sabine Kliesch, Peter Albers, Christoph Oing
Therapy of clinical stage IIA and IIB seminoma: a systematic review. World journal of urology (2021)
Richard J Rebello, Christoph Oing, Karen E Knudsen, Stacy Loeb, David C Johnson, Robert E Reiter, Silke Gillessen, Theodorus Van der Kwast, Robert G Bristow
Prostate cancer. Nature reviews. Disease primers 7 (1) (2021)
Vera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, Rita Guimarães, Mariana Cantante, Isaac Braga, Joaquina Maurício, Christoph Oing, Friedemann Honecker, Daniel Nettersheim, Leendert H J Looijenga, Rui M Henrique, Carmen Jerónimo
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Christoph Oing, Mia-Carlotta Peters, Felix Bremmer
[What does the oncologist need from the pathologist in testicular cancer?] Der Pathologe 41 (Suppl 2) (2021)
A Radtke, K-P Dieckmann, F Grobelny, A Salzbrunn, Christoph Oing, W Schulze, Gafanzer Belge
Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration. Andrology 7 (4) (2020)
Mohamed E Elsesy, Su Jung Oh-Hohenhorst, Anastassia Löser, Christoph Oing, Sally Mutiara, Sabrina Köcher, Stefanie Meien, Alexandra Zielinski, Susanne Burdak-Rothkamm, Derya Tilki, Hartwig Huland, Rudolf Schwarz, Cordula Petersen, Carsten Bokemeyer, Kai Rothkamm, Wael Y Mansour
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. Cancers 12 (9) (2020)
Georg Richtig, Erika Richtig, Alexandra Böhm, Christoph Oing, Farastuk Bozorgmehr, Stephan Kruger, Barbara Kiesewetter, Christoph Zielinski, Anna Sophie Berghoff
Awareness of predatory journals and open access among medical oncologists: results of an online survey. ESMO open 4 (6) (2019)
Richard J Rebello, Christoph Oing, Silke Gillessen Sommer, Robert G Bristow
TP53 and Prognosis in mCRPC Survival: Biology or Coincidence? Clinical cancer research : an official journal of the American Association for Cancer Research 25 (6) (2019)
Winfried Alsdorf, Christoph Seidel, Carsten Bokemeyer, Christoph Oing
Current pharmacotherapy for testicular germ cell cancer. Expert opinion on pharmacotherapy 20 (7) (2019)
Christoph Oing, Margaretha A Skowron, C Bokemeyer, Daniel Nettersheim
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations. Andrology 7 (4) (2019)
Christoph Oing, Marcus Hentrich, Anja Lorch, Dietrich Gläser, Holger Rumpold, Sebastian Ochsenreither, Stephan Richter, Annette Dieing, Stefanie Zschäbitz, Ronnie Rodrigues Pereira, Carsten Bokemeyer, Christoph Seidel
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series. Journal of cancer research and clinical oncology 146 (2) (2019)
Christoph Oing, Christoph Seidel, Carsten Bokemeyer
Therapeutic approaches for refractory germ cell cancer. Expert review of anticancer therapy 18 (4) (2018)
Christoph Oing, Izudin Verem, Wael Yassin Mansour, Carsten Bokemeyer, Sergey A Dyshlovoy, Friedemann Honecker
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells. International journal of molecular sciences 20 (1) (2018)
Christoph Oing, Winfried H Alsdorf, Gunhild von Amsberg, Karin Oechsle, Carsten Bokemeyer
Platinum-refractory germ cell tumors: an update on current treatment options and developments. World journal of urology 35 (8) (2016)

Christoph Oing.css-eqlu8i{font-size:small;padding-left:4px;} (C Oing)

Publication Activity (10 Years)

Top Topics

Top Venues

Christoph Oing (C Oing)